Images from Wockhardt's Manufacturing Facilities As Indian Pharmaceuticals Breach Quality Control


Women shelter their heads from the rain outside the Wockhardt Ltd.... News PhotoAdult,Asia,Built Structure,Factory,Finance,Geographical Locations,Healthcare And Medicine,Horizontal,India,Indian Subcontinent,Indian Subcontinent Ethnicity,Industry,Maharashtra,Manufacturing,Medicine,Rain,Sheltering,WomenPhotographer Collection: Bloomberg 2013 BloombergWomen shelter their heads from the rain outside the Wockhardt Ltd. manufacturing facility in the Chikalthana industrial area in Aurangabad, India, on Monday, Sept. 16, 2013. Wockhardt currently controls about 26 percent of the U.S. market for metoprolol, a generic version of the heart pill sold by London-based AstraZeneca Plc under the brand name Toprol-XL, according to Needham & Co. Metoprolol alone makes up about 14 percent of the company's 56 billion rupees in annual revenue. Photographer: Dhiraj Singh/Bloomberg via Getty Images